Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Karlén

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Journal of Medicinal Chemistry|April 1, 1989
Topography and conformational preferences of 6,7,8,9-tetrahydro-1-hydroxy-N,N-dipropyl-5H-benzocyclohepten-6- ylamin e. A rationale for the dopaminergic inactivityA Karlén, A Helander, L Kenne, et al.
Progress in Clinical and Biological Research|January 1, 1989
Why are benzocycloheptenylamines inactive as dopamine D2-receptor agonists?A Karlén, U Hacksell, A Helander, et al.
Bioorganic & Medicinal Chemistry|October 12, 2000
Comparison of three gamma-turn mimetic scaffolds incorporated into angiotensin IIS Lindman, G Lindeberg, F Nyberg, et al.
The Journal of Pharmacy and Pharmacology|December 6, 2001
Effects of cholesterol and model transmembrane proteins on drug partitioning into lipid bilayers as analysed by immobilized-liposome chromatographyC Lagerquist, F Beigi, A Karlén, et al.
Drug Design and Discovery|June 1, 1993
Conformational properties of melatonin and two conformationally restricted agonists: a molecular mechanics and NMR spectroscopic studyJ M Jansen, A Karlén, C J Grol, et al.
Drug Design and Discovery|February 1, 1994
Dopamine D2 receptor agonists: an analysis of indirect modelsA M Johansson, C J Grol, A Karlén, et al.
Methods in Enzymology|January 1, 1991
Molecular electrostatic potentials for characterizing drug-biosystem interactionsP A Carrupt, N el Tayar, A Karlén, et al.
Bioorganic & Medicinal Chemistry|April 20, 2001
Synthesis, receptor binding affinities and conformational properties of cyclic methylenedithioether analogues of angiotensin IIS Lindman, G Lindeberg, A Gogoll, et al.
Journal of Medicinal Chemistry|March 3, 1999
Bicyclic tripeptide mimetics with reverse turn inducing propertiesP Johannesson, G Lindeberg, W Tong, et al.
Journal of Medicinal Chemistry|June 1, 1986
Conformational analysis of the dopamine-receptor agonist 5-hydroxy-2-(dipropylamino)tetralin and its C(2)-methyl-substituted derivativeA Karlén, A M Johansson, L Kenne, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Journal of Medicinal Chemistry|April 1, 1989
Topography and conformational preferences of 6,7,8,9-tetrahydro-1-hydroxy-N,N-dipropyl-5H-benzocyclohepten-6- ylamin e. A rationale for the dopaminergic inactivityA Karlén, A Helander, L Kenne, et al.
Progress in Clinical and Biological Research|January 1, 1989
Why are benzocycloheptenylamines inactive as dopamine D2-receptor agonists?A Karlén, U Hacksell, A Helander, et al.
Bioorganic & Medicinal Chemistry|October 12, 2000
Comparison of three gamma-turn mimetic scaffolds incorporated into angiotensin IIS Lindman, G Lindeberg, F Nyberg, et al.
The Journal of Pharmacy and Pharmacology|December 6, 2001
Effects of cholesterol and model transmembrane proteins on drug partitioning into lipid bilayers as analysed by immobilized-liposome chromatographyC Lagerquist, F Beigi, A Karlén, et al.
Drug Design and Discovery|June 1, 1993
Conformational properties of melatonin and two conformationally restricted agonists: a molecular mechanics and NMR spectroscopic studyJ M Jansen, A Karlén, C J Grol, et al.
Drug Design and Discovery|February 1, 1994
Dopamine D2 receptor agonists: an analysis of indirect modelsA M Johansson, C J Grol, A Karlén, et al.
Methods in Enzymology|January 1, 1991
Molecular electrostatic potentials for characterizing drug-biosystem interactionsP A Carrupt, N el Tayar, A Karlén, et al.
Bioorganic & Medicinal Chemistry|April 20, 2001
Synthesis, receptor binding affinities and conformational properties of cyclic methylenedithioether analogues of angiotensin IIS Lindman, G Lindeberg, A Gogoll, et al.
Journal of Medicinal Chemistry|March 3, 1999
Bicyclic tripeptide mimetics with reverse turn inducing propertiesP Johannesson, G Lindeberg, W Tong, et al.
Journal of Medicinal Chemistry|June 1, 1986
Conformational analysis of the dopamine-receptor agonist 5-hydroxy-2-(dipropylamino)tetralin and its C(2)-methyl-substituted derivativeA Karlén, A M Johansson, L Kenne, et al.
Pageof 3